JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer
Clinical trial NCT05664971 · COMPLETED
Trial details
- NCT number
- NCT05664971
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-09
- Primary completion
- 2025-10-23
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.